Priory rolls out £3,375 five-week anxiety rehab for ages 12-18

The Priory's move into pediatric anxiety rehabilitation puts a private hospital known for adult addiction treatment into the centre of the youth mental health crisis. For clinicians and health-system planners, the £3,375 five-week course targets emotionally based school avoidance with exposure therapy in an in-house school, but raises immediate clinical and equity questions about access, evidence and NHS capacity.

The Priory Group, one of the UK's best-known private mental-health and addiction providers, has launched what it describes as the first programme of its kind for children avoiding school because of anxiety. Offered at its south-west London flagship hospital, the five-week course is aimed at 12-to-18-year-olds, costs £3,375, and uses exposure therapy inside the hospital's in-house school to rebuild the confidence needed for classroom attendance. The Priory will accept NHS referrals, according to The Sunday Telegraph, even though the course itself is run privately.

“

The Priory operates roughly 270 sites across the UK and has historically been associated with celebrity addiction treatment, including Eric Clapton, Amy Winehouse and Robbie Williams.

There is a meaningful difference between ordinary back-to-school nerves and emotionally based school avoidance, and the programme's lead clinician, Dr Maria Zioga, makes that distinction explicit. She argues that children and young people who experience this are not being 'difficult', 'lazy' or lacking care about their education, and that many want to attend school. That framing matters because it shifts the problem from a disciplinary or attendance issue to a mental-health condition requiring specialist intervention.

The Priory operates roughly 270 sites across the UK and has historically been associated with celebrity addiction treatment, including Eric Clapton, Amy Winehouse and Robbie Williams. Its entry into pediatric school-refusal treatment is therefore both an expansion into a new clinical market and a reputational pivot from adult rehab to adolescent anxiety. The in-house school component is critical because it recreates the environmental trigger, pairing exposure to a classroom setting with therapeutic support rather than treating anxiety in isolation from school context.

The £3,375 fee immediately raises questions about equity. If families self-fund, only those with substantial means can access immediate help while others wait for NHS child and adolescent mental health services. If NHS referrals are funded, the model could relieve some pressure on public services, but it would do so by purchasing private capacity rather than increasing public provision. The price point is therefore both a demand signal and an access bottleneck, illustrating how far the UK is from universal, timely support for school-related anxiety.